Premium
Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesions
Author(s) -
Kanodia Shreya,
Da Silva Diane M.,
Kast W. Martin
Publication year - 2007
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.23252
Subject(s) - immunotherapy , human papillomavirus , medicine , immunology , immune system
Human papillomavirus (HPV)‐induced lesions are distinct in that they have targetable foreign antigens, the expression of which is necessary to maintain the cancerous phenotype. Hence, they pose as a very attractive target for “proof of concept” studies in the development of therapeutic vaccines. This review will focus on the most recent clinical trials for the immunotherapy of mucosal and cutaneous HPV‐induced lesions as well as emerging therapeutic strategies that have been tested in preclinical models for HPV‐induced lesions. Progress in peptide‐based vaccines, DNA‐based vaccines, viral/bacterial vector‐based vaccines, immune response modifiers, photodynamic therapy and T cell receptor based therapy for HPV will be discussed. © 2007 Wiley‐Liss, Inc.